Comparison of efficacy, safety, and convenience of selamectin versus ivermectin for treatment of Trixacarus caviae mange in pet guinea pigs (Cavia porcellus).
To determine the efficacy and safety of topical administration of selamectin and to compare selamectin treatment with a common ivermectin protocol for the treatment of natural infestation with Trixacarus caviae in pet guinea pigs. Clinical trial. 17 mixed-breed pet guinea pigs with active mite infestation. Guinea pigs were randomly allocated to receive a single dose of selamectin topically (15 mg/kg [6.8 mg/lb]) or ivermectin (400 μg/kg [181.8 μg/lb], SC) every 10 days for 4 injections. Microscopic examination of skin scrapings from all animals was performed at 10-day intervals for 60 days, and the presence of mites or mite eggs was recorded. The efficacies of the 2 treatment protocols were compared at every time point. Pruritus resolved by day 10 in all animals. Animals were microscopically mite-free on days 30 and 40 in the selamectin and ivermectin treatment groups, respectively, but groups did not differ significantly in regard to the number of mite-positive animals at any timepoint. Recurrence of infection was not noted in either treatment group. No adverse reactions were observed in any of the treated animals. Results suggested that a single topical application of selamectin at a dose of 15 mg/kg or repeated SC injection of ivermectin at a dose of 400 μg/kg can eliminate T caviae mites from guinea pigs within 30 and 40 days, respectively. Although effectiveness did not significantly differ between the 2 treatments, the convenience associated with the single topical dose of selamectin made it a preferable treatment modality for both patients and owners.